2014
DOI: 10.5021/ad.2014.26.4.526
|View full text |Cite
|
Sign up to set email alerts
|

Autohemotherapy in Chronic Urticaria: What Could Be the Autoreactive Factors and Curative Mechanisms?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
8
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 8 publications
2
8
0
Order By: Relevance
“…Yu [18] Incomplete or internal inconsistent results in abstract; full article not available Jeon [53] No results related to research questions Sheikhi [54] Insufficient detail in letter to compute effect size or describe design; no further information available Nahm [55] Treatment consisted of autologous immunoglobulin, not whole blood or serum…”
Section: Reason For Exclusionmentioning
confidence: 99%
“…Yu [18] Incomplete or internal inconsistent results in abstract; full article not available Jeon [53] No results related to research questions Sheikhi [54] Insufficient detail in letter to compute effect size or describe design; no further information available Nahm [55] Treatment consisted of autologous immunoglobulin, not whole blood or serum…”
Section: Reason For Exclusionmentioning
confidence: 99%
“…The etiology of CU is not well understood, and the majority of cases are considered idiopathic or due to autoreactivity [4]. At this time, neither European nor US guidelines recommend extensive laboratory testing or skin biopsy [2].…”
Section: Pathogenesismentioning
confidence: 99%
“…For antihistamine‐resistant patients, omalizumab, a humanized anti‐IgE antibody and, if ineffective, ciclosporin A are recommended treatment options . However, in some countries, such as China, Germany, India, Iran, South Korea, Turkey, Mexico and the United States, autohemotherapy is also commonly used to treat antihistamine‐resistant patients with CSU . As of now, the level of evidence in support of the efficacy of autohemotherapy in the treatment of patients with CSU is limited and the mechanisms of action are currently not well understood, which is why autohemotherapy as a treatment approach in CSU is controversially discussed (Appendix , Supporting Information).…”
Section: Introductionmentioning
confidence: 99%